News & Events

Au revoir CPhI Paris

From the 7th until the 10th October the Symbiosis team attended CPhI, one of Europe’s largest pharmaceutical conferences held in Paris, France. Our two European Business Development Managers and our CEO were in attendance at the event with support from our friends at Scottish Development International. Thanks to those of you who visited our stand, especially given the challenges of navigating the multiple exhibition halls and the Paris transport systems! The conference was attended by delegates from around the world and our team used this opportunity to both network with some familiar faces and to meet new contacts from the pharmaceutical industry.

Attendance at the exhibition was good and the team felt the quality of potential new projects was exceptional, with some very interesting discussions being held. The recent forced exit from the market of a number of UK-based CMO’s with sterile manufacturing capabilities was a topic many were keen to discuss. The Symbiosis facility in Stirling was designed and built with aseptic manufacturing as its core capability. Licensed by the MHRA and successfully inspected as recently as June, the cGMP manufacture of sterile drug products is our core business and where our expertise lies. We understand that by offering our clients short lead times to manufacturing slots along with rapid batch release that their development timelines are minimised and long-term mutually beneficial relationships are built.

Our team especially enjoyed the cheese and wine boat cruise on the river Seine hosted by Outsourcing Pharma. And thanks to our colleagues at Scottish Development International for hosting the whisky tasting reception: always enjoyed by our clients.

Some of our regular readers may remember the “Find the Nessie” challenge we ran at CPhI. True to the legend, Nessie was seen only once then disappeared on day one…the mystery may never be solved.

Hope to see you at CPhI 2015 in Madrid!

Symbiosis Pharmaceutical Services is a world class specialist in the manufacturing of sterile injectable drugs for clinical trials and niche commercial marketed products. Our aim is to successfully reduce our clients’ drug development times. Contact Symbiosis at

Get In Touch.

By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.